Cargando…

Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients

Detalles Bibliográficos
Autores principales:	Wu, Zhiyong, Hu, Rui, Zhang, Cuizhen, Ren, Wei, Yu, Anfeng, Zhou, Xiaoyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273814/ https://www.ncbi.nlm.nih.gov/pubmed/32503680 http://dx.doi.org/10.1186/s13054-020-03015-0

Ejemplares similares

Neurological effects of elevated levels of angiotensin II in COVID-19 patients
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Elevated plasma hemoglobin in COVID-19–related illnesses: a critical appraisal
por: Tiwari, Nishant R., et al.
Publicado: (2020)

Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children
por: Wang, Guan, et al.
Publicado: (2022)

Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
por: Chappell, Mark C., et al.
Publicado: (2021)

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
por: Camargo, Rafael L., et al.
Publicado: (2022)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

On-line plasma lactate concentration monitoring in critically ill patients
por: De Tymowski, Christian, et al.
Publicado: (2017)

Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019
por: van Lier, Dirk, et al.
Publicado: (2022)

Plasma concentrations of caspofungin in a critically ill patient with morbid obesity
por: Ferriols-Lisart, Rafael, et al.
Publicado: (2017)

Plasma exchange in critically ill COVID-19 patients
por: Morath, Christian, et al.
Publicado: (2020)

Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?
por: Tralhão, António, et al.
Publicado: (2020)

In critically ill patients the procalcitonin level can be misleading
por: Koeze, Jacqueline, et al.
Publicado: (2011)

Serum levels of kisspeptin are elevated in critically ill patients
por: Luedde, Mark, et al.
Publicado: (2018)

Increased circulating levels of angiotensin-(1–7) in severely ill COVID-19 patients
por: Valle Martins, Ana Luiza, et al.
Publicado: (2021)

Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients
por: van Lier, Dirk, et al.
Publicado: (2021)

Angiotensin II in vasodilatory shock: lights and shadows
por: Antonucci, Elio, et al.
Publicado: (2017)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

Serum Lipase Elevations in COVID-19 Patients Reflect Critical Illness and not Acute Pancreatitis
por: Ramsey, Mitchell L., et al.
Publicado: (2021)

Insulin and the critically ill
por: Das, Undurti N
Publicado: (2002)

Angiotensin II in ECMO patients: a word of caution
por: Antonucci, Elio, et al.
Publicado: (2019)

Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill
por: Bitker, Laurent, et al.
Publicado: (2019)

Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients
por: Astola Hidalgo, I., et al.
Publicado: (2023)

Plasma Nitric Oxide Consumption Is Elevated and Associated With Adverse Outcomes in Critically Ill Patients
por: Dony, Christina A., et al.
Publicado: (2023)

Treatment with angiotensin II in COVID-19 patients may not be beneficial
por: Rysz, Susanne, et al.
Publicado: (2020)

Tissue Doppler in critical illness
por: Chew, Michelle, et al.
Publicado: (2007)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

His345 mutant of angiotensin-converting enzyme 2 (ACE2) remains enzymatically active against angiotensin II
por: Liu, Pan, et al.
Publicado: (2021)

The role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19
por: Biberoğlu, Serap, et al.
Publicado: (2021)

Renin–angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report
por: Eleuteri, Davide, et al.
Publicado: (2021)

Fasting and nutrient-stimulated plasma peptide-YY levels are elevated in critical illness and associated with feed intolerance: an observational, controlled study
por: Nguyen, Nam Q, et al.
Publicado: (2006)

Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia
por: Junus, Katja, et al.
Publicado: (2022)

Persistently elevated osteopontin serum levels predict mortality in critically ill patients
por: Roderburg, Christoph, et al.
Publicado: (2015)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Hyperlactatemia in critical illness and cardiac surgery
por: O'Connor, Enda D, et al.
Publicado: (2010)

Bedside handover of critically ill patients
por: Wise, Matt P, et al.
Publicado: (2012)

Advances in antibiotic therapy in the critically ill
por: Jia, Rufu, et al.
Publicado: (2016)

Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19
por: Lancman, Guido, et al.
Publicado: (2020)

The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database
por: Zhu, Xu, et al.
Publicado: (2022)

Critical illness is associated with elevated parathyroid hormone
por: Zaloga, GP, et al.
Publicado: (2001)

Cytokine plasma levels during weaning in critically ill patients with sepsis
por: Cerny, V, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_tmjd0oohfmglltmf1o1tkhhss0